Home | Product No Longer Available place holder

Product No Longer Available


This product G-Protein Coupled Receptors (GPCRs) is not longer available for purchase.

You may find what you're looking for in the following list of products.


place holder place holder place holder place holder place holder place holder place holder place holder

Results for 'G-Protein Coupled Receptors (GPCRs)'

Title Sort Publication Date Sort Price Sort Relevance Sort
place holder


G-Protein Coupled Receptors (GPCRs) 2007

 September 2007 £2350 98 %
Lead Optimization Strategies
An analysis of novel molecular targets to develop innovative new therapeutics

 January 2005 £1495 32.9 %
Global Pipeline Review & Analysis of Hematological Malignancies

 March 2007 £1665 26.5 %
Pancreatic Cancer Drug Pipeline Update 2007

 May 2007 £1015 18.5 %
Breast Cancer Drug Pipeline Update 2006

 May 2007 £1015 18 %
Antibodies in Oncology
Drug Pipeline Update 2007

 May 2007 £1015 18 %
Liver Cancer Drug Pipeline Update 2007

 May 2007 £680 18 %
Ovarian Cancer Drug Pipeline Update 2007

 May 2007 £1015 18 %
Brain Cancer Drug Pipeline Update 2007

 May 2007 £1525 18 %
Lymphoma Drug Pipeline Update 2006

 May 2007 £1015 18 %
Bladder Cancer Drug Pipeline Update 2007

 May 2007 £680 18 %
Immunotherapy in Oncology
Drug Pipeline Update 2007

 May 2007 £1355 18 %
CRC Drug Pipeline Update 2005

 May 2007 £1015 17.5 %
Prostate Cancer - A Therapeutic & Competitive Insight
Drug Pipeline Update 2007

 May 2007 £1015 17.5 %
Leukemia Drug Pipeline Update 2006

 May 2007 £1015 17.5 %
Hematological Cancers Drug Pipeline Update 2006

 May 2007 £1355 17.5 %
Melanoma Drug Pipeline Update 2007

 May 2007 £1015 17.5 %
Novel Targets in Drug Discovery
A new era in therapy

 April 2004 £595 17.5 %
Lung Cancer Drug Pipeline Update 2006

 May 2007 £1015 17 %
Renal Cancer Drug Pipeline Update 2007

 May 2007 £1015 16.5 %
Decoding Big Pharmas R&D Strategy in Oncology

 September 2007 £2495 15.75 %
Decoding Big Pharma's R&D Strategy in Oncology

 September 2007 £1665 15.4 %
Decoding Big Pharma's R&D Strategy in Oncology

 September 2007 £1665 15.4 %
Decoding Big Pharma's R&D Strategy in Oncology

 September 2007 £1665 15.4 %
Decoding Big Pharma's R&D Strategy in Oncology

 September 2007 £1665 15.4 %
Cancer Antibodies
Competitive Positioning for Success

 June 2008 £1535 12.95 %
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Breast- and Prostate Cancer

 June 2007 £3510 11.2 %
Pipeline Insight: Migraine
Innovation essential as weak late-stage pipeline fails to hold off the impact of triptan patent expiries

 December 2006 £6000 11 %
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Leukemias and Lymphomas

 June 2007 £3510 10.85 %
Drug Discovery Handbook

 July 2005 £94.5 9.45 %
Drug Delivery in Central Nervous System Diseases
technologies,markets and companies

 September 2008 £1340 8.4 %
Proteomics
Technologies, Markets and Companies

 September 2008 £1875 8.05 %
place holder